Fig. 2From: Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver diseaseV9 treatment improves HFD-induced metabolic disorder. a Hepatic levels of TG. b Hepatic levels of FFA. c Hepatic levels of Glycogen. d Fasting glucose levels in serum. Data are expressed as mean ± SD with n = 8, **P < 0.01 vs HFD groupBack to article page